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Abstract
Mutations in the orphan gene C19orf12 were identified as a genetic cause in a subgroup of patients with NBIA, a
neurodegenerative disorder characterized by deposits of iron in the basal ganglia. C19orf12 was shown to be localized in
mitochondria, however, nothing is known about its activity and no functional link exists to the clinical phenotype of the
patients. This situation led us to investigate the effects of C19orf12 down-regulation in the model organism Drosophila
melanogaster. Two genes are present in D. melanogaster, which are orthologs of C19orf12, CG3740 and CG11671. Here we
provide evidence that transgenic flies with impaired C19orf12 homologs reflect the neurodegenerative phenotype and
represent a valid tool to further analyze the pathomechanism in C19orf12-associated NBIA.
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Introduction
NBIA refers to a heterogeneous group of rare (1–3 cases/1
million population) inherited neurological disorders whose hall-
mark is iron deposition in the basal ganglia. Currently, nine
different subtypes of NBIA have been recognized and associated to
their genetic counterpart. PANK2, PLA2G6 and C19orf12 are hot
spot genes, with C19orf12 accounting alone for up to 30% of cases.
Most of the knowledge about C19orf12-associated NBIA refers to
genetic, clinical and radiological features. So far, 67 patients have
been reported in literature [1–9] but still no hypothesis has been
made concerning the pathomechanism underlying this complex
disorder. Two postmortem brain samples were examined and
showed iron accumulation, Lewy bodies, tau pathology and
spheroids with a strong immunoreactivity for ubiquitin. However,
the scarcity of cases makes it difficult to state whether the overlap
between C19orf12-associated NBIA and Parkinson’s disease is a
rule or a private trait.
C19orf12 expression occurs mainly in brain, blood cells and
adipocytes. During in vitro adipocyte differentiation C19orf12
expression increases constantly and is co-regulated with genes
involved in the fatty acid metabolism suggesting a role for
C19orf12 in lipid metabolism [1].
C19orf12 harbors two trans-membrane domains. Immunoflu-
orescence experiments have shown that C19orf12 is localized in
mitochondria. Based on these evidences, MPAN (Mitochondrial
membrane Protein-Associated Neurodegeneration) has been
proposed as acronym to refer to C19orf12-associated NBIA.
Although C19orf12 is a mitochondrial protein, mutations in
C19orf12 do not appear to affect the mitochondrial bioenergetics in
fibroblasts under basal conditions [1].
The scarcity of data available from neuropathology, the
limitations of investigating the biochemical basis of the disease
directly in the brain, the absence of a phenotype in fibroblasts and
the lack of homology to proteins with known function, led us to
work on the creation of a model that would allow us to study the
consequences of impaired C19orf12 in tissues which are primarily
affected. We decided to set up a D. melanogaster model. Drosophila
was successfully employed to study pantothenate kinase-associated
neurodegeneration (PKAN) resulting from mutations in PANK2
[10,11] and tested in rescue experiments with pantethine [12]. We
identified two D. melanogaster orthologs of C19orf12, CG3740 and
CG11671. We used double heterozygous deletion flies and an
RNAi approach to down-regulate the expression of both genes
providing evidence that the orthologs are required for the
maintenance of the brain tissue and the normal locomotor
function. Our results suggest that Drosophila can be used to gain
further insight in MPAN disorder.
Results and Discussion
Drosophila has Two Orthologs of the Human C19orf12
Comparative genomics revealed that the human C19orf12 gene
has two orthologs in D. melanogaster, CG3740 and CG11671, which
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share 63% and 55%, respectively, of similarity at protein level with
C19orf12 (NP_001026896.2) (Figure 1). CG3740 is localized on
the X-chromosome in position 2B5–2B5 while CG11671 maps to
chromosome 3R in position 84F8–84F8. The two Drosophila genes
are proposed to originate by a duplication event at the speciation
node explaining their 72% similarity. The transmembrane domain
is the only feature of C19orf12 that is predicted by the primary
amino acidic sequence. PolyPhobius program [13] predicted two
transmembrane domains for CG3740, similar to the human
protein, and one long one for CG11671. Aside the prediction, it is
also possible that CG11671 has two transmembrane domains
which would also fit with the length of the predicted domain
(Figure 1). CG3740 and CG11671 are differentially expressed
(Figure 2). The analysis of the mRNA expression pattern in head,
thorax and abdomen of adult w1118 flies revealed that expression
levels of CG3740 are comparable among the tissues tested, while
CG11671 expression is low in head and high in abdomen.
Generation of Double RNAi and Double Heterozygous
Deletion Flies
In order to analyze the consequences of impaired activity we
made use of the bipartite GAL4-UAS system. Transgenic lines
carrying the yeast Upstream Activating Sequence (UAS) in front of
the RNAi constructs for both CG3740 and CG11671 were
available at the Vienna Drosophila RNAi stock collection [14].
Both RNAi lines were separately crossed with specific driver lines
expressing GAL4 under the control of elav, tubulin or actin
promoters, enabling knockdown of CG3740 and CG11671 gene
products at the neuronal level (elav) or in the whole body (actin,
tubulin). Quantitative PCR performed in RNA isolated from heads
of 10 days-old flies revealed that the strongest knockdown was
induced under the actin promotor expression, leaving mRNAs
levels of only 25% for CG3740 or 10% for CG11671 (Figure 3A).
However, down-regulation of the product of each single gene did
not result in any significant difference in lifespan or climbing
activity compared to control flies (data not shown).
Based on the homology between CG3740 and CG11671 and the
overlapping expression pattern, we hypothesized a compensative
mechanism between the two genes that can justify the absence of
any pathological phenotype. Hence we generated a stock carrying
both RNAi transgenes and crossed these flies with the driver line
act-GAL4 in order to reduce compensatory effects between
CG3740 and CG11671 (Figure S1). Quantitative PCRs performed
on heads of 10 days-old flies showed a reduction of at least 40% for
CG3740 and 75% for CG11671 in double RNAi transgenic flies
(Figure 3A).
In a second approach, heterozygous deletion strains for CG3740
and CG11671 were generated to validate RNAi fly phenotypes.
For this purpose, w1118 flies were crossed with Df(1)BSC589 and
Df(3)BSC579 flies, two lines carrying macro deletions encompass-
ing CG3740 and CG11671 respectively and several other genes.
Moreover, Df(1)BSC589 and Df(3)BSC579 lines were crossed
between each other in order to generate double heterozygous
deletion flies (Figure S2). All heterozygous deletion flies were
morphologically normal. Quantitative PCRs performed showed
expression levels comparable to RNAi transgenes (Figure 3B).
Double RNAi Flies Have Reduced Median Lifespan
The lifespan of control w1118 and double RNAi flies was
determined under standard growth conditions by counting the
number of dead flies every second day. Down-regulated flies
revealed a significantly reduced median lifespan of about 8 days at
50% survival (Figure 4).
Double RNAi and Double Heterozygous Deletion Flies
Show Defective Climbing
NBIA patients with defective C19orf12 display spasticity and
progressive cognitive decline. Onset generally occurs in childhood
up to early adulthood with slow progression and survival well into
adulthood [1,15]. Although double RNAi and double deletion flies
are able to walk, climb and fly, we noticed that they recovered
more slowly after the application of a force by tapping them to the
lower part of the vial. Those flies able to recover and climb were
slower than the controls. We quantified the behavioral defects.
Since locomotion can be affected by the age, we tested flies of two
different ages using age-matched controls for all tests. In addition,
two different control strains were used in the assay, the canonical
wild-type w1118 and the act-GAL4/+ flies obtained by backcrossing
act-GAL4 for 6 generations with w1118 (Text S1). When analyzing
young flies no differences between double RNAi, double deletion
Figure 1. Alignment of the fly C19orf12 orthologs (CG3740, CG11671) with human C19orf12 protein. Proteins have been aligned using
Clustal 2.1 multiple alignment tool. Stars (*) indicate identities and dots indicate a higher (:) and a lower (.) degree of similarity. The two D.
melanogaster proteins are 63% and 55% similar to C19orf12 and share 72% similarity with each other. The transmembrane domains predicted by
PolyPhobius are marked in yellow.
doi:10.1371/journal.pone.0089439.g001
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Figure 2. Expression of CG3740 and CG11671 in head, thorax and abdomen of D. melanogaster. The analysis has been performed on total
RNA extracted from adult w1118 flies using the same number of males and females (n = 4). The Ribosomal Protein 49 has been used as endogenous
control to normalize CG3740 and CG11671 expression level. The level of CG11671 in the abdomen has been set to 1 and the expression of CG3740 and
CG11671 in the other tissues expressed relatively.
doi:10.1371/journal.pone.0089439.g002
Figure 3. Expression of CG3740 and CG11671 in heads from 10 days-old flies. The Ribosomal Protein 49 has been used as endogenous
control to normalize CG3740 and CG11671 expression level. (A) CG3740 and CG11671 have been measured in single RNAi flies (CG3740 RNAi and
CG11671 RNAi) and in double RNAi flies (CG3740; CG11671 RNAi) using the same number of males and females (n = 4). The level of CG3740 and
CG11671 in control flies has been set to 1 and the expression of both genes in down-regulated flies expressed relatively. (B) CG3740 and CG11671
have been measured in single heterozygous deletion flies (Df(1)BSC589/+ and Df(3L)BSC579/+) and in double heterozygous deletion flies
(Df(1)BSC589/+; Df(3L)BSC579/+) using female flies (n = 4). The level of CG3740 and CG11671 in control flies has been set to 1 and the expression of
both genes in heterozygous deletion flies expressed relatively. Data refer to the average of three independent experiments 6 SD.
doi:10.1371/journal.pone.0089439.g003
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and control flies were observed. However, 4-weeks-old double
RNAi and double deletion flies performed poorly in the climbing
assay compared to controls (Figure 5). Only few down-regulated
flies were able to reach the end point fixed at the 150 ml line (17.5
cm) of a cylinder in fifteen seconds. The majority only initiated
climbing and stopped before the endpoint was reached, fell back
or did not initiate climbing. This behavior suggested a neuromus-
cular phenotype in double RNAi and double heterozygous
deletion flies.
Double RNAi Flies Present Vacuoles in the Brain
Since the hallmark of NBIA is iron accumulation in the brain,
we searched for iron accumulation in fly brains of double RNAi
flies. The presence of iron deposits was investigated using the
standard Prussian blue staining on paraffin-embedded brains of
aged flies using sections of mouse spleen as a positive control for
the staining. Under our experimental conditions we could not find
iron deposits (Figure 6).
We morphologically analyzed brains for signs of neurodegen-
eration in order to investigate whether the defective climbing
coincided with abnormalities in the nervous system. In Drosophila,
the tissue loss is typically detected as accumulation of degenerative
vacuoles or holes in the brain [16,17]. For this we analyzed the
morphology of brains from 28 days-old double RNAi and age-
matched control flies. A high number of vacuoles with an area up
to 30 mm2 was found in the brain and in the optical lobe of all
investigated down-regulated flies suggesting a neurodegenerative
process. Few small vacuoles below 2 mm2 were also found in one
control fly as a normal result of the aging process [18] (Figure 7A–
B).
Double RNAi and Double Heterozygous Deletion Flies
Present Bang Sensitivity
In order to further analyze possible locomotor defects, we
subjected young and adult double RNAi and double heterozygous
flies to mechanical stress by vortexing them shortly and banging
Figure 4. Kaplan-Maier curve of control (w1118) and double RNAi male flies (n =100). The median lifespan is 33 days for control flies vs. 25
days for down-regulated flies. The difference was statistically evaluated by Log Rank test (p = 0.02).
doi:10.1371/journal.pone.0089439.g004
Figure 5. Climbing activity in young (1 day-old) and aged (1 month-old) control (w1118 and act-GAL4/+), double RNAi and double
heterozygous flies. The average is given for 50 animals in each group.
doi:10.1371/journal.pone.0089439.g005
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the vial against a hard surface. Often, a compromised mitochon-
drial metabolism generates bang sensitive mutants which respond
to the mechanical boost with a temporary paralysis [19]. Control
flies restored the upright position instantly and climbed the vial
(Movie S1; Movie S2). Double RNAi flies failed to recover a
correct body position promptly even if no signs of paralysis or
failure of movements were present (Movie S3; Movie S4). They
frantically moved their legs and bodies and jumped repeatedly
from one side to the other of the vial before getting the upright
position and climbing the tube. Double heterozygous deletion flies
actually restored the upright position instantly, like controls, but
ceased moving. No flies climbed up (Figure 8; Movies S1, S2, S3,
and S4).
Figure 6. Prussian blue staining for detection of iron deposits. The staining was performed on paraffin-embedded sections of 28 days-old
flies. No iron deposits were detected in the medulla or retina of either controls or double RNAi flies. Clear iron inclusions were present in paraffin-
embedded sections of mouse spleen (positive control).
doi:10.1371/journal.pone.0089439.g006
Figure 7. Detection of vacuoles in ultrathin Epon plastic sections. A) Horizontal head sections from 28 days-old control (w1118) and down-
regulated (CG3740; CG11671 RNAi) flies. B) Number and size of vacuoles have been quantified with Image J running the applications ‘‘Find Edges’’ and
‘‘Analyze Particles’’ on thresholded 8-bit pictures. Particle size was imposed bigger than 20 pixels2 and with a circularity factor between 0,5 and 1.
Detected vacuoles were displayed using ‘‘Overlay Mask’’. Data were manually validated to exclude artifacts. Brains analyzed for each fly strain: n = 3.
Scale bar: 100 mm.
doi:10.1371/journal.pone.0089439.g007
A Drosophila Model for C19orf12-Associated NBIA
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Concluding Remarks
Drosophila models have been successfully applied as a tool to
unravel basic mechanisms underlying a large number of human
neurodegenerative disorders such as Parkinson’s disease [20],
Alzheimer [21,22], Non-coding Trinucleotide Repeat diseases
[23] and PKAN [10,11]. Here we provide compelling evidence
that an in vivo model for MPAN has been generated by down-
regulating the two homologues of C19orf12. The uncoordinated
behavior or lack of orientation in the bang test, the impaired
climbing activity as well as the shorter lifespan and the
morphological alterations in brain suggest that double RNAi flies
can be used as a model for MPAN. The presence of locomotor
impairment and bang sensitivity also in double heterozygous
deletion flies provides additional genetic evidence that the
phenotypes detected in double RNAi flies are due to the knock-
down of CG3740 and CG11671 rather than due to off-target
effects. The availability of CG3470; CG11671 down-regulated flies
provide affected tissues, like brain or muscles which are the main
targets of NBIA disorders but seldom available for functional




Fly stocks were maintained routinely in our lab at 22uC
according to standard protocols. As wild type stock w1118 and act-
GAL4/+ were used. UAS-CG3740 (FBst0477282), UAS-CG11671
(FBst0463955) transgenic lines were obtained from Vienna
Drosophila RNAi Center (Vienna, Austria); w1118 (BL5905),
act5C-GAL4/CyO (BL4414), CyO/snaSco (BL2555), CyO/snaSco;
TM6B/MKRS (BL2551), Df(1)BSC589 w1118/FM7h/Dp(2;Y)G,
P{hs-hid}Y (BL25423), w1118; Df(3L)BSC579/TM6C, cu1 Sb1
(BL25413) were from Bloomington Drosophila Stock Centre
(Indiana University, USA). UAS-CG3740/CyO; UAS-CG11671/
TM6B strain, Df(1)BSC589/+, Df(3L)BSC579/+ and
Df(1)BSC589/+; Df(3L)BSC579/+ were generated in this work.
Chromosomes 1, 3, 4 of the driver line act5C-GAL4/CyO were
isogenized to the genetic background of control w1118 flies by back
crossing it for 6 generations. Control act-GAL4/+ flies were
obtained by back crossing w1118 with act-GAL4 flies for 6
generations (Text S1).
RNA Extraction and qPCR
Flies were cut in three parts: head, thorax and abdomen. Four
specimens from each part were collected, resuspended in 500 ml of
Trizol (Invitrogen) and homogenized using a teflon pestle. Total
Figure 8. Bang test in young (1 day-old) and aged (1 month-old) control (w1118 and act-GAL4/+) and double RNAi males. A) Flies have
been vortexed twice (Bang I and II) with 10 minutes in between and the time needed to upright recorded. A) Representative trajectories are reported
for aged control (green), double RNAi (red) and for double heterozygous (blue) flies.
doi:10.1371/journal.pone.0089439.g008
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RNA was isolated using the Trizol method. One microgram of
RNA was reversely transcribed using the M-MLV Reverse
Transcriptase (Promega) and oligo dT. CG3740 and CG11671
expression were evaluated in comparison to the ribosomal protein
49. The following primers were used:
CG3740_F: 59 GGCTGTGCTTAACACTGTCAT 39.
CG3740_R: 59 CTACACTGATCACAAAGGTTTC 39.
CG11671_F: 59 CAGGGCCATATCCGAAGTTA 39.
CG11671_R: 59 TGGTCATTCCCATACGATCA 39.
Rp49_F: 59 ATCGGTTACGGATCGAACA 39.
Rp49_R: 59 ACAATCTCCTTGCGCTTCTT 39.
DyNAmo Flash SYBR Green qPCR kit (Finzymes) was used for
qPCR and the reactions were run on ABI7900HT instrument
(Applied Biosystem). qPCRs have been performed in triplicate on
RNA isolated each time from 4 flies.
Behavioral Assays
Two groups of flies, corresponding to ‘‘young’’ (i.e. 24 h after
eclosion) and ‘‘aged’’ (i.e. 4 weeks after eclosion) populations of
wild-type, double RNAi and double heterozygous deletion flies,
were tested in the behavioral assays. Assays were carried out with
male and female down-regulated flies and with female double
heterozygous deletion flies. Flies were CO2-treated and separated
into groups with the same number of individuals per vial one day
before the test. Hence flies were subjected to the climbing assay
and to the bang test.
The climbing assay was performed according to a modified
version of Benzer [24]. 50 flies were placed in a 250-ml glass
graduated cylinder that was sealed at the top with parafilm to
prevent escape. The flies were gently knocked to the bottom of the
cylinder and the number of flies able to cross the 150-ml line
(17.5 cm) in 15 seconds was recorded.
The test for bang sensitivity was performed as described by
Zhang [25]. Flies were vortexed at maximum setting for 10 sec
(Bang I) and the time until all flies upright themselves was
recorded. To test for refractory period, the flies were vortexed
again 10 min later to see if the flies were still bang sensitive (Bang
II). For control as well as mutants, 50 flies were tested for each age.
Statistical analyses were performed using Student’s t-test. Data
are presented as mean 6 Standard Deviation.
Longevity Test
100 males for control and mutant were collected immediately
after eclosion. Every 2 or 3 days flies were passed on fresh food and
the number of survived flies plotted in an excel graph until their
death.
Brain Histology
Analysis of heads from 28-day-old double RNAi flies and aged
matched controls were fixed in 0.1M sodium cacodylate, 2.5%
paraformaldehyde, 2.5% gluteraldehyde and embedded in epon.
One micrometer horizontal sections were cut for each head.
Section from different brain depths were checked for the presence
of vacuoles. Sections were stained with 1% toluidine-blue and 1%
borax and investigated with an Olympus BX50 light microscope.
The number and size of vacuoles was quantified with Image J.
For detection of ferric iron, paraffin embedded sections were
incubated for 45 minutes with Prussian blue stain (10%
K4Fe(CN)6: 20% HCl, 1:1) prior to de-paraffinization. Three
washes with water followed and staining was enhanced using DAB
following standard procedures. Afterwards, the sections were de-
paraffinized using ascending gradients of ethanol to xylene and
preparation were mounted in Permount mounting medium (Fisher
Scientific) and imaged on a Olympus BX50 light microscope.
Supporting Information
Figure S1 Generation of double RNAi Flies. UAS-CG3740
and UAS-CG11671 flies have been crossed respectively with the
double balancer CyO/snaSco; TM6B/MKRS to block any
recombination on the second and on the third chromosome.
Hence selected parental lines have been crossed between each
other in order to get the double balanced stock UAS-CG3740/
CyO; UAS-CG11671/TM6. The homozygous stock UAS-
CG3740/UAS-CG3740; UAS-CG11671/UAS-CG11671, pro-
duced by backcrossing balanced males and females, has been
crossed with act-GAL4 driver line to get the double RNAi flies.
(TIF)
Figure S2 Generation of double heterozygous deletion
Flies. Flies carrying deficiencies on chromosomes 1 (BL25423)
and 3 (BL25413) have been crossed with wild type flies w1118 to
generate single heterozygous deletion flies for CG3740 and
CG11671. Then deficiency stocks have been crossed between
each other in order to get the double heterozygous deleted stock
Df(1)BSC589/+; Df(3L)BSC579/+.
(TIF)
Text S1 Generation of act-GAL4/+ flies. Act5C-GAL4/
CyO (BL4414) and CyO/snaSco (BL2555) flies, were backcrossed
with w1118 flies for 6 generations to produce control flies isogenic
with w1118 for chromosomes 1, 3, and 4.
(DOCX)
Movie S1 First bang test, bang I, in control w1118 flies.
Males and females were contemporary vortexed for 10 seconds at
maximum speed and the time required for recovering the upright
position recorded.
(MOV)
Movie S2 Second bang test, bang II, in control w1118
flies. Males and females were contemporary vortexed, for 10
seconds at the maximum speed, 10 minutes after the first bang.
The time required to recover the upright position recorded.
(MOV)
Movie S3 First bang test, bang I, in double RNAi flies.
Males and females were contemporary vortexed for 10 seconds at
maximum speed and the time required for recovering the upright
position recorded.
(MOV)
Movie S4 Second bang test, bang II, in double RNAi
flies. Males and females were contemporary vortexed, for 10
seconds at the maximum speed, 10 minutes after the first bang.
The time required to recover the upright position recorded.
(MOV)
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